AAAAAA

   
Results: 1-18 |
Results: 18
GENETIC DIVERSITY AMONG MYCOBACTERIUM-AVIUM COMPLEX STRAINS RECOVEREDFROM CHILDREN WITH AND WITHOUT HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: SWANSON DS PAN X KLINE MW MCKINNEY RE YOGEV R LEWIS LL BRADY MT MCSHERRY GD DANKNER WM MUSSER JM
Citation: Ds. Swanson et al., GENETIC DIVERSITY AMONG MYCOBACTERIUM-AVIUM COMPLEX STRAINS RECOVEREDFROM CHILDREN WITH AND WITHOUT HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, The Journal of infectious diseases, 178(3), 1998, pp. 776-782
COMPARATIVE TRIAL OF 2 DOSAGES OF ZALCITABINE IN ZIDOVUDINE-EXPERIENCED CHILDREN WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE
Authors: SPECTOR SA BLANCHARD S WARA DW OLESKE JM MCINTOSH K HODES D DANKNER WM SALGO M MCNAMARA J
Citation: Sa. Spector et al., COMPARATIVE TRIAL OF 2 DOSAGES OF ZALCITABINE IN ZIDOVUDINE-EXPERIENCED CHILDREN WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE, The Pediatric infectious disease journal, 16(6), 1997, pp. 623-626
NOSOCOMIAL TRANSMISSION OF M-BOVIS-BCG TO CHILDREN ON CANCER-CHEMOTHERAPY (CHEMORX) AND TO THEIR HEALTH-CARE WORKERS (HCW)
Authors: WAECKER NJ DANKNER WM STEFANOVA R CAVE MD DAVIS CE
Citation: Nj. Waecker et al., NOSOCOMIAL TRANSMISSION OF M-BOVIS-BCG TO CHILDREN ON CANCER-CHEMOTHERAPY (CHEMORX) AND TO THEIR HEALTH-CARE WORKERS (HCW), Clinical infectious diseases, 23(4), 1996, pp. 153-153
ZIDOVUDINE PHARMACOKINETICS IN PREMATURE-INFANTS EXPOSED TO HIV
Authors: CAPPARELLI EV MIROCHNICK MH DANKNER WM
Citation: Ev. Capparelli et al., ZIDOVUDINE PHARMACOKINETICS IN PREMATURE-INFANTS EXPOSED TO HIV, Pediatric research, 39(4), 1996, pp. 994-994
ABDOMINAL TUBERCULOSIS IN CHILDREN - REVIEW OF 26 CASES
Authors: VEERAGANDHAM RS LYNCH FP CANTY TG COLLINS DL DANKNER WM
Citation: Rs. Veeragandham et al., ABDOMINAL TUBERCULOSIS IN CHILDREN - REVIEW OF 26 CASES, Journal of pediatric surgery, 31(1), 1996, pp. 170-176
VIROLOGICAL MARKERS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN CEREBROSPINAL-FLUID OF INFECTED CHILDREN
Authors: PRATT RD NICHOLS S MCKINNEY N KWOK S DANKNER WM SPECTOR SA
Citation: Rd. Pratt et al., VIROLOGICAL MARKERS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN CEREBROSPINAL-FLUID OF INFECTED CHILDREN, The Journal of infectious diseases, 174(2), 1996, pp. 288-293
RANDOMIZED STUDY OF THE TOLERANCE AND EFFICACY OF HIGH-DOSE VERSUS LOW-DOSE ZIDOVUDINE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN WITH MILD-TO-MODERATE SYMPTOMS (AIDS CLINICAL-TRIALS GROUP 128)
Authors: BRADY MT MCGRATH N BROUWERS P GELBER R FOWLER MG YOGEV R HUTTON N BRYSON YJ MITCHELL CD FIKRIG S BORKOWSKY W JIMENEZ E MCSHERRY G RUBINSTEIN A WILFERT CM MCINTOSH K ELKINS MM WEINTRUB PS BERNSTEIN L SHLIOZBERG J LIVINGSTON RA VINK P FLAUTT L KLINE MW RAYBORN T KAUL A LAWRENCE R CHANDWANI S RUBINHALE A KNOXBURKE K ALATTAR I COOPER ER PELTON SI REGAN AM DAMON B YOUNG B NOZYCE M CIHAK P WIZNIA A CHADWICK EG SILIO M KLAUKE BJ OLESKE JM COLABELLI NB CONNOR EM GERSHON A PITT J SHEA K CLARK P CERVIA JS EDELSON PJ SANDERSLAUFER D HINDS GA RAKUSAN TA SEVER J HERZOG K ELLAURIE M MCKINNEY RE LANE BA SANTACROCE S NESHEIM SR SAWYER M SARVER J MEADOWS L ABRAMS E KANEM N FRERE M URBANO R RAGNI MV MILLER B CARFAGNA E MENDEZ H HANDLESMAN E DIFILIPPO G BERGIN HF SHAH K RAO S VILLARICA NC CLINTRON AA HODES D BARZELAI A BUTLER L HEATON S GUPTA A AHERN L MUNOZ J LI K BAMJI M KENNEDY G DUMMITT M PAHWA S BAKSJI S HUNKLER JA CALLAWAY CC CRIM LB DIAZ C RIVERA C FLORES L BEAUCHAMP B DIAZ L AGUAYO R GARCIATRIAS DE FRENKEL LD GAUR S SCUDDER RC KECHULA IM LISCHNER HW GREGONIS SW TRESTON CS RAPHAEL SA CARRER MT PEREZ L BERRIOS Z BURCHETT SK MELVIN AJ COREY L MOHAN KM GRIECO M MCKINLEY G RIVERA J MOALLEN H SCHULLER G PRAMBERG JC ALCHEDIAK T VANDYKE RB CALLIGARO D CHURCH J DEVEIKIS A GILETTE S SPECTOR SA DANKNER WM INSTONE S STANGLE L WARA DW PETRU A WILLIAMSHERMAN D BAKER RC SIEGEL R MCOWEN N ROBINSON J WELLS L JOHNSON GM RICH KC HAYANI K TURPIN D SULLIVAN JL LUZURIAGA K STECHENBERG BW ROBINSON JE LIM W DUDEK V MUNDORF L SANTUCCI S FRENKEL L LAMBERT JS MURANTE B SCOTT GB GOURLEY J MENDOZA C DOYLE M CANTINI M
Citation: Mt. Brady et al., RANDOMIZED STUDY OF THE TOLERANCE AND EFFICACY OF HIGH-DOSE VERSUS LOW-DOSE ZIDOVUDINE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN WITH MILD-TO-MODERATE SYMPTOMS (AIDS CLINICAL-TRIALS GROUP 128), The Journal of infectious diseases, 173(5), 1996, pp. 1097-1106
SURVEILLANCE FOR CONGENITAL CYTOMEGALOVIRUS DISEASE - A REPORT FROM THE TIONAL-CONGENITAL-CYTOMEGALOVIRUS-DISEASE-REGISTRY
Authors: ISTAS AS DEMMLER GJ DOBBINS JG STEWART JA ADLER S BALE JF MURPH J BRADY MT CHERNESKY MA CHONMAITREE T COEN RW COURTNEY J DANKNER WM FORDJONES EL GARCIA J ATKINS JT GEHRZ R GIVNER L GRUBER WC KENNY JF KEYSERLING HL KINNEY JS KOVACS A KUMAR ML LEACH CT MARSHALL GS RABALAIS G MONTGOMERY JR MURPHY D PATAMASUCON P NEWPORT MT PASS R BOPPANA SB SHELTON M SOKOL D STAMOS JK ROWLEY AH STARR S WEINER LB GROSS J HUTTO C RUPAR DG
Citation: As. Istas et al., SURVEILLANCE FOR CONGENITAL CYTOMEGALOVIRUS DISEASE - A REPORT FROM THE TIONAL-CONGENITAL-CYTOMEGALOVIRUS-DISEASE-REGISTRY, Clinical infectious diseases, 20(3), 1995, pp. 665-670
PHARMACOKINETIC, SAFETY, AND ANTIVIRAL PROFILES OF ORAL GANCICLOVIR IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - A PHASE I II STUDY/
Authors: SPECTOR SA BUSCH DF FOLLANSBEE S SQUIRES K LALEZARI JP JACOBSON MA CONNOR JD JUNG D SHADMAN A MASTRE B BUHLES W DREW WL DANKNER WM MEIXNER L FREEMAN WR DYNER TS FREEMAN E MORTILLARO G GLUTZER E BUSH T COLEMAN R
Citation: Sa. Spector et al., PHARMACOKINETIC, SAFETY, AND ANTIVIRAL PROFILES OF ORAL GANCICLOVIR IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - A PHASE I II STUDY/, The Journal of infectious diseases, 171(6), 1995, pp. 1431-1437
MULTICENTER TRIAL OF TOWNE STRAIN ATTENUATED VIRUS-VACCINE IN SERONEGATIVE RENAL-TRANSPLANT RECIPIENTS
Authors: PLOTKIN SA HIGGINS R KURTZ JB MORRIS PJ CAMPBELL DA SHOPE TC SPECTOR SA DANKNER WM
Citation: Sa. Plotkin et al., MULTICENTER TRIAL OF TOWNE STRAIN ATTENUATED VIRUS-VACCINE IN SERONEGATIVE RENAL-TRANSPLANT RECIPIENTS, Transplantation, 58(11), 1994, pp. 1176-1178
VIROLOGICAL MARKERS OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) IN CEREBROSPINAL-FLUID (CSF) OF INFECTED CHILDREN
Authors: PRATT RD NICHOLS S DANKNER WM SPECTOR SA
Citation: Rd. Pratt et al., VIROLOGICAL MARKERS OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) IN CEREBROSPINAL-FLUID (CSF) OF INFECTED CHILDREN, Pediatric research, 35(4), 1994, pp. 10000192-10000192
IMPACT OF MATERNAL GROUP-B STREPTOCOCCUS (GBS) CHEMOPROPHYLAXIS REGIME N ON THE INCIDENCE OF NEONATAL GBS DISEASE AT A UNIVERSITY HOSPITAL (UCSD) - A 5-YEAR RETROSPECTIVE REVIEW
Authors: DANKNER WM AHMANN K MOORE T
Citation: Wm. Dankner et al., IMPACT OF MATERNAL GROUP-B STREPTOCOCCUS (GBS) CHEMOPROPHYLAXIS REGIME N ON THE INCIDENCE OF NEONATAL GBS DISEASE AT A UNIVERSITY HOSPITAL (UCSD) - A 5-YEAR RETROSPECTIVE REVIEW, Pediatric research, 35(4), 1994, pp. 10000296-10000296
CONTROLLED TRIAL OF INTRAVENOUS IMMUNE GLOBULIN FOR THE PREVENTION OFSERIOUS BACTERIAL-INFECTIONS IN CHILDREN RECEIVING ZIDOVUDINE FOR ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: SPECTOR SA GELBER RD MCGRATH N WARA D BARZILAI A ABRAMS E BRYSON YJ DANKNER WM LIVINGSTON RA CONNOR EM SHEARER WT DOYLE M HANSON CG LAFLEN J PELTON SI COOPER ER REGAN AM TOLTZIS P ZUCKER M CHANCE M YOGEV R CHADWICK E BAKER RC SIEGEL R PITT J GERSHON AA KANEM N NESHEIM SR NAHMIAS AJ KEYSERLING HL SAWYER MK DOSSETT J EYSTER ME CUBBLE LJ YOLKEN R MODLIN J VINK P WARFORD R HEATON S HODES D SACKS HS MCSHERRY G OLESKE J PICARDI J COLABELLI N GUPTA A BORKOWSKY W CHANDWANI S RIGAUD M KAUL A BRADY MT HUNKLER JA CRIM LB BONAGURA VR VALACER DJ BAKSHI S GRIECO MH RIVERS J MCKINLEY G FIKRIG S VANDYKE RB ALCHEDIAK T DEVEIKIS A WONG V CHURCH J DORENBAUM A PETRU A TREBITHICK D RICH K CHEESEMAN S SULLIVAN JL LUZURIAGA K JONES CR GOODROAD BK BALFOUR HH DIAZ C LUGO L FLORES L RIVERA C BURCHETT SK MOHAN K FOSTER I COREY L STORCH G BREUKLANDER L ROYAL M
Citation: Sa. Spector et al., CONTROLLED TRIAL OF INTRAVENOUS IMMUNE GLOBULIN FOR THE PREVENTION OFSERIOUS BACTERIAL-INFECTIONS IN CHILDREN RECEIVING ZIDOVUDINE FOR ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, The New England journal of medicine, 331(18), 1994, pp. 1181-1187
CLINICAL-SIGNIFICANCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PHENOTYPES IN INFECTED CHILDREN
Authors: SPENCER LT OGINO MT DANKNER WM SPECTOR SA
Citation: Lt. Spencer et al., CLINICAL-SIGNIFICANCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PHENOTYPES IN INFECTED CHILDREN, The Journal of infectious diseases, 169(3), 1994, pp. 491-495
HIV-1 PHENOTYPE IN PERINATALLY INFECTED CHILDREN
Authors: SPENCER LT DANKNER WM SPECTOR SA
Citation: Lt. Spencer et al., HIV-1 PHENOTYPE IN PERINATALLY INFECTED CHILDREN, Journal of cellular biochemistry, 1993, pp. 57-57
PRENATAL-DIAGNOSIS OF CONGENITAL CYTOMEGALOVIRUS-INFECTION - FALSE-NEGATIVE AMNIOCENTESIS AT 20 WEEKS GESTATION
Authors: CATANZARITE V DANKNER WM
Citation: V. Catanzarite et Wm. Dankner, PRENATAL-DIAGNOSIS OF CONGENITAL CYTOMEGALOVIRUS-INFECTION - FALSE-NEGATIVE AMNIOCENTESIS AT 20 WEEKS GESTATION, Prenatal diagnosis, 13(11), 1993, pp. 1021-1025
PATHOPHYSIOLOGY AND TREATMENT OF CLINICALLY RESISTANT CYTOMEGALOVIRUSRETINITIS
Authors: FLORESAGUILAR M KUPPERMANN BD QUICENO JI DANKNER WM WOLF DG CAPPARELLI EV CONNOR JD SHERWOOD CH FULLERTON S GAMBERTOGLIO JG SPECTOR SA FREEMAN WR
Citation: M. Floresaguilar et al., PATHOPHYSIOLOGY AND TREATMENT OF CLINICALLY RESISTANT CYTOMEGALOVIRUSRETINITIS, Ophthalmology, 100(7), 1993, pp. 1022-1031
DEVELOPMENT AND SIGNIFICANCE OF ZIDOVUDINE RESISTANCE IN CHILDREN INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: OGINO MT DANKNER WM SPECTOR SA
Citation: Mt. Ogino et al., DEVELOPMENT AND SIGNIFICANCE OF ZIDOVUDINE RESISTANCE IN CHILDREN INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, The Journal of pediatrics, 123(1), 1993, pp. 1-8
Risultati: 1-18 |